JPH0330573B2 - - Google Patents

Info

Publication number
JPH0330573B2
JPH0330573B2 JP57502882A JP50288282A JPH0330573B2 JP H0330573 B2 JPH0330573 B2 JP H0330573B2 JP 57502882 A JP57502882 A JP 57502882A JP 50288282 A JP50288282 A JP 50288282A JP H0330573 B2 JPH0330573 B2 JP H0330573B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57502882A
Other versions
JPS58501590A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US30437281A priority Critical
Application filed filed Critical
Publication of JPS58501590A publication Critical patent/JPS58501590A/ja
Publication of JPH0330573B2 publication Critical patent/JPH0330573B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/29Antimony or bismuth compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
JP57502882A 1981-09-22 1982-09-21 Expired - Lifetime JPH0330573B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US30437281A true 1981-09-22 1981-09-22

Publications (2)

Publication Number Publication Date
JPS58501590A JPS58501590A (ja) 1983-09-22
JPH0330573B2 true JPH0330573B2 (ja) 1991-04-30

Family

ID=23176246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57502882A Expired - Lifetime JPH0330573B2 (ja) 1981-09-22 1982-09-21

Country Status (17)

Country Link
EP (1) EP0075992B1 (ja)
JP (1) JPH0330573B2 (ja)
AT (1) AT15598T (ja)
AU (1) AU563692B2 (ja)
CA (1) CA1198367A (ja)
DE (1) DE3266403D1 (ja)
DK (1) DK160533C (ja)
ES (1) ES515848A0 (ja)
FI (1) FI77156C (ja)
GR (1) GR78040B (ja)
HU (1) HU193524B (ja)
IE (1) IE53958B1 (ja)
NZ (1) NZ201911A (ja)
PH (1) PH20649A (ja)
PT (1) PT75550B (ja)
WO (1) WO1983001001A1 (ja)
ZA (1) ZA8206893B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU590578B2 (en) * 1985-04-18 1989-11-09 Procter & Gamble Company, The Treatment of non-ulcer dyspepsia with bismuth salts
AT79261T (de) * 1985-06-13 1992-08-15 Barry James M D Marshall Verfahren zur behandlung von magen-darmstoerungen.
EP0462631B1 (en) * 1985-06-13 1996-03-20 Barry James Dr. Marshall Methods and compositions for the treatment of gastrointestinal disorders
HU205861B (en) * 1986-12-19 1992-07-28 Sandoz Ag Process for producing hydrosole of pharmaceutically effective material
DE3901508C2 (de) * 1989-01-19 1994-04-07 Falk Pharma Gmbh Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form
IT1229502B (it) * 1989-01-25 1991-09-03 Euroresearch Srl Composizioni contenenti bismuto idonee per uso terapeutico.
IE893167A1 (en) * 1989-10-04 1991-04-24 Ulso Lab Ltd Preparation of orally administrable liquids for use in¹therapy
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
AU5439696A (en) * 1995-08-24 1997-03-19 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms
AU4596796A (en) * 1995-02-07 1996-08-27 Narayan Krishnarao Athanikar Concomitant treatment with bismuth and antibacterials
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
RU2496719C1 (ru) * 2012-02-17 2013-10-27 Федеральное государственное бюджетное учреждение науки Институт химии твердого тела и механохимии Сибирского отделения РАН (ИХТТМ СО РАН) Способ получения висмут калий цитрата
RU2570610C1 (ru) * 2014-10-02 2015-12-10 Федеральное государственное бюджетное учреждение науки Институт химии твердого тела и механохимии Сибирского отделения РАН (ИХТТМ СО РАН) Способ получения висмут аммоний цитрата
RU2675869C1 (ru) * 2018-02-05 2018-12-25 Общество с ограниченной ответственностью "Брайт Вэй" Способ получения висмут-калий-аммоний цитрата

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA7400385B (en) * 1974-01-18 1975-08-27 Gist Brocades Nv Pharmaceutical compositions

Also Published As

Publication number Publication date
FI77156B (fi) 1988-10-31
DK208083A (da) 1983-05-10
EP0075992A1 (en) 1983-04-06
IE53958B1 (en) 1989-04-26
CA1198367A (en) 1985-12-24
IE822299L (en) 1983-03-22
NZ201911A (en) 1985-10-11
PT75550A (en) 1982-10-01
DK160533B (da) 1991-03-25
ES515848D0 (ja)
AT15598T (de) 1985-10-15
FI831815D0 (ja)
FI831815A0 (fi) 1983-05-20
ES515848A0 (es) 1983-10-16
FI831815A (ja)
FI77156C (fi) 1989-02-10
DK160533C (da) 1991-09-09
JPS58501590A (ja) 1983-09-22
DK208083D0 (da) 1983-05-10
PT75550B (en) 1984-12-12
EP0075992B1 (en) 1985-09-18
PH20649A (en) 1987-03-16
ZA8206893B (en) 1983-07-27
FI831815L (fi) 1983-05-20
AU8950382A (en) 1983-04-08
HU193524B (en) 1987-10-28
WO1983001001A1 (en) 1983-03-31
AU563692B2 (en) 1987-07-16
DE3266403D1 (en) 1985-10-24
GR78040B (ja) 1984-09-26
ES8400240A1 (es) 1983-10-16
CA1198367A1 (ja)

Similar Documents

Publication Publication Date Title
FR2503896B1 (ja)
JPS594216B2 (ja)
JPH0143038B2 (ja)
JPH0419496B2 (ja)
FR2501896B1 (ja)
JPH0343212B2 (ja)
JPH0156666B2 (ja)
JPH0325981B2 (ja)
JPH0150138B2 (ja)
JPH0211074B2 (ja)
JPH032170B2 (ja)
DE3221256C2 (ja)
FR2503382B1 (ja)
JPS58501890A (ja)
IN156401B (ja)
DE3222576C2 (ja)
JPH022722B2 (ja)
JPS6040770B2 (ja)
JPS58501859A (ja)
FR2499212B1 (ja)
JPS6318009Y2 (ja)
JPH0138848B2 (ja)
JPH0142210B2 (ja)
JPH0141725B2 (ja)
DE3140294C2 (ja)